Concord Drugs Ltd banner
C

Concord Drugs Ltd
BSE:538965

Watchlist Manager
Concord Drugs Ltd
BSE:538965
Watchlist
Price: 78.06 INR 4.09% Market Closed
Market Cap: ₹780.6m

Cash Flow Statement

Cash Flow Statement
Concord Drugs Ltd

Rotate your device to view
Cash Flow Statement
Currency: INR
Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024 Mar-2025
Operating Cash Flow
Net Income
5
5
43
56
22
11
12
22
6
(7)
7
Depreciation & Amortization
15
21
14
18
18
16
16
15
16
15
14
Other Non-Cash Items
14
23
12
15
14
10
16
18
19
19
20
Cash Taxes Paid
1
2
5
9
7
3
4
6
2
(1)
2
Cash Interest Paid
14
23
12
15
14
10
16
18
19
19
20
Change in Working Capital
(9)
(9)
(53)
(47)
(46)
(71)
(28)
(42)
(33)
(32)
(4)
Cash from Operating Activities
25
N/A
39
+56%
16
-58%
42
+159%
8
-82%
(33)
N/A
17
N/A
12
-25%
8
-36%
(5)
N/A
37
N/A
Investing Cash Flow
Capital Expenditures
(8)
(19)
(37)
(36)
(0)
7
(9)
(7)
(10)
(10)
(23)
Other Items
0
0
0
0
0
0
(14)
(14)
0
0
0
Cash from Investing Activities
(8)
N/A
(19)
-128%
(37)
-91%
(36)
+1%
0
N/A
7
+5 978%
(23)
N/A
(21)
+5%
(10)
+53%
(10)
0%
(23)
-129%
Financing Cash Flow
Net Issuance of Common Stock
9
9
0
0
0
0
19
19
7
0
0
Net Issuance of Debt
(3)
41
34
(28)
35
64
(2)
(1)
5
17
6
Other
(24)
(29)
(13)
(16)
(18)
(14)
(11)
(8)
(9)
(13)
(20)
Cash from Financing Activities
(18)
N/A
20
N/A
21
+3%
(44)
N/A
17
N/A
51
+203%
6
-88%
10
+62%
3
-72%
11
+288%
(14)
N/A
Change in Cash
Net Change in Cash
(1)
N/A
40
N/A
0
-99%
(39)
N/A
25
N/A
25
+2%
0
-99%
1
+418%
1
-40%
(4)
N/A
(0)
+94%
Free Cash Flow
Free Cash Flow
16
N/A
20
+19%
(21)
N/A
5
N/A
8
+43%
(26)
N/A
8
N/A
5
-36%
(2)
N/A
(15)
-577%
14
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett